W.ZhanP.YangH
This distinction matters: if youre taking Wegovy, youre on a weight loss medication by design, not off-label
Tirzepatide and semaglutide are GLP-1 receptor agonists, but Tirzepatides dual agonism offers distinct advantages
Patients should never accelerate the titration schedule without medical guidance, as this may worsen side effects without improving therapeutic outcomes
Just as importantly, the symptoms patients attribute to "low GH" fatigue, poor recovery, low energy overlap heavily with hypothyroidism, depression, sleep apnea, and low testosterone, so those causes should be ruled out first
She is a certified medical specialist and Menopause Society certified menopause practitioner